{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": "Arunachalam_et_al.__2021_",
  "verification_stats": {
    "total_extracted": 7,
    "verified": 6,
    "rejected": 1,
    "verification_rate": 0.8571428571428571
  },
  "verified_evidence": [
    {
      "id": 1,
      "quote": "The recombinant quadrivalent influenza vaccine (RIV4, Flublok\u00ae, Supemtek\u00ae [EU, Canada], Sanofi pasteur) was the first licensed influenza vaccine to be produced using recombinant viral proteins instead of antigens derived from live influenza virus (as for inactivated split virion and subunit vaccines). RIV4 is an unadjuvanted vaccine containing 45 \u00b5g of HA/dose from each of the four strains. The production of RIV4 is based on a novel production platform in which recombinant HA (rHA) is expressed in insect cells using a baculovirus expression vector system (BEVS)22. In brief, expresSF+ insect cells are infected with recombinant baculovirus carrying the relevant influenza HA genes, which are expressed under the control of a baculovirus polyhedrin promoter.",
      "supports_claim": true,
      "explanation": "The quote appears in the document on page 2, starting with: 'The recombinant quadrivalent influenza vaccine (RIV4, Flublok\u00ae, Supemtek\u00ae [EU, Canada], Sanofi pasteur) was the first licensed influenza vaccine to be produced using recombinant viral proteins instead of antigens derived from live influenza virus (as for inactivated split virion and subunit vaccines). RIV4 is an unadjuvanted vaccine containing 45 \u00b5g of HA/dose from each of the four strains. The production of RIV4 is based on a novel production platform in which recombinant HA (rHA) is expressed in insect cells using a baculovirus expression vector system (BEVS)22. In brief, expresSF+ insect cells are infected with recombinant baculovirus carrying the relevant influenza HA genes, which are expressed under the control of a baculovirus polyhedrin promoter.' The factual content, technical details, and structure of the quote are preserved, with only minor formatting and spacing differences.. The quote directly and explicitly states that Flublok (RIV4) is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). This matches the claim exactly, providing both the method (recombinant HA in insect cells) and the technology (baculovirus expression vector system), and even names the vaccine (Flublok). No inference is required; the quote fully and unambiguously supports the claim.",
      "presence_explanation": "The quote appears in the document on page 2, starting with: 'The recombinant quadrivalent influenza vaccine (RIV4, Flublok\u00ae, Supemtek\u00ae [EU, Canada], Sanofi pasteur) was the first licensed influenza vaccine to be produced using recombinant viral proteins instead of antigens derived from live influenza virus (as for inactivated split virion and subunit vaccines). RIV4 is an unadjuvanted vaccine containing 45 \u00b5g of HA/dose from each of the four strains. The production of RIV4 is based on a novel production platform in which recombinant HA (rHA) is expressed in insect cells using a baculovirus expression vector system (BEVS)22. In brief, expresSF+ insect cells are infected with recombinant baculovirus carrying the relevant influenza HA genes, which are expressed under the control of a baculovirus polyhedrin promoter.' The factual content, technical details, and structure of the quote are preserved, with only minor formatting and spacing differences.",
      "support_explanation": "The quote directly and explicitly states that Flublok (RIV4) is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). This matches the claim exactly, providing both the method (recombinant HA in insect cells) and the technology (baculovirus expression vector system), and even names the vaccine (Flublok). No inference is required; the quote fully and unambiguously supports the claim.",
      "original_relevance": "This quote explicitly states that Flublok (RIV4) is produced using a novel platform where recombinant HA is expressed in insect cells using a baculovirus expression vector system, directly supporting the claim."
    },
    {
      "id": 2,
      "quote": "This review focuses on the structural features of BEVS derived rHA that make RIV4 unique from conventional vaccines, and how these features help to maximise vaccine performance.",
      "supports_claim": true,
      "explanation": "The quote appears verbatim in the document: 'This review focuses on the structural features of BEVS derived rHA that make RIV4 unique from conventional vaccines, and how these features help to maximise vaccine performance.' This is found on page 2 of the document. The factual content and meaning are preserved.. The quote directly states that RIV4 (Flublok) contains recombinant HA (rHA) derived from a baculovirus expression vector system (BEVS), which is the novel production platform referenced in the claim. This explicitly supports the claim that Flublok is produced using a novel platform in which recombinant HA is expressed in insect cells using BEVS.",
      "presence_explanation": "The quote appears verbatim in the document: 'This review focuses on the structural features of BEVS derived rHA that make RIV4 unique from conventional vaccines, and how these features help to maximise vaccine performance.' This is found on page 2 of the document. The factual content and meaning are preserved.",
      "support_explanation": "The quote directly states that RIV4 (Flublok) contains recombinant HA (rHA) derived from a baculovirus expression vector system (BEVS), which is the novel production platform referenced in the claim. This explicitly supports the claim that Flublok is produced using a novel platform in which recombinant HA is expressed in insect cells using BEVS.",
      "original_relevance": "This quote confirms that RIV4 (Flublok) uses recombinant HA derived from a baculovirus expression vector system (BEVS), supporting the claim about its novel production platform."
    },
    {
      "id": 3,
      "quote": "Fig. 2 Structural features of native HA expressed on influenza virus and rHA produced in insect cells using the baculovirus expression vector system. a HA protein (shown as monomer) extracted from influenza virus is a heterodimer comprising HA1 (turquoise) and HA2 (orange) linked though an inter disulfide (S-S) bond and contains complex type sialylated N-linked glycans. Cleaved fusion peptides (green) and complex glycans74 eliminate and mask unique epitopes on HA respectively. b Recombinant HA protein (shown as monomer) expressed in",
      "supports_claim": true,
      "explanation": "The quote appears on page 4 of the document as the caption for Figure 2: 'Fig. 2 Structural features of native HA expressed on influenza virus and rHA produced in insect cells using the baculo virus expression vector system. a HA protein (shown as monomer) extracted from influenza virus is aheterodimer comprising HA1 (turquoise) and HA2 (orange) linked though an inter disulfide (S-S) bond and contains complex type sialylated N-linked glycans. Cleaved fusion peptides (green) and complex glycans74 eliminate and mask unique epi to pes on HA respectively. b Recombinant HA protein (shown as monomer) expressed in'. The wording and factual content are semantically equivalent to the quote to verify, with only minor formatting and spacing differences.. The quote directly states that recombinant HA (rHA) is produced in insect cells using the baculovirus expression vector system. This matches the claim that Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). The figure caption explicitly describes the production method, providing clear and direct support for the claim.",
      "presence_explanation": "The quote appears on page 4 of the document as the caption for Figure 2: 'Fig. 2 Structural features of native HA expressed on influenza virus and rHA produced in insect cells using the baculo virus expression vector system. a HA protein (shown as monomer) extracted from influenza virus is aheterodimer comprising HA1 (turquoise) and HA2 (orange) linked though an inter disulfide (S-S) bond and contains complex type sialylated N-linked glycans. Cleaved fusion peptides (green) and complex glycans74 eliminate and mask unique epi to pes on HA respectively. b Recombinant HA protein (shown as monomer) expressed in'. The wording and factual content are semantically equivalent to the quote to verify, with only minor formatting and spacing differences.",
      "support_explanation": "The quote directly states that recombinant HA (rHA) is produced in insect cells using the baculovirus expression vector system. This matches the claim that Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). The figure caption explicitly describes the production method, providing clear and direct support for the claim.",
      "original_relevance": "This figure caption and description directly state that recombinant HA for RIV4 is produced in insect cells using the baculovirus expression vector system, providing clear evidence for the claim."
    },
    {
      "id": "comp_1",
      "quote": "RECOMBINANT HA EXPRESSION SYSTEMS Both prokaryotic and eukaryotic expression systems have been used for the manufacture of rHA vaccine antigens. ... Several groups have explored the use of adeno virus (AdV), primarily as a replication defective vector, for gene delivery and trans gene expression of rHA in the host cells. ... by integrating HA, cap sid protein (M1) and neuraminidase (NA) expressed in insect cells 44 46. Although presenting proteins in VLP structures enhanced their immunogen i city, it compromised the purity of the vaccines considerably, as VLP structures also integrated both baculo virus and Sf9 cell proteins. ... Insect cell derived rHA (RIV4) has been studied extensively by various groups in both pre clinical models and humans.",
      "supports_claim": true,
      "explanation": "The quote appears on page 3 of the document, though with some minor differences in formatting and wording due to OCR correction. The content is semantically equivalent: it discusses both prokaryotic and eukaryotic expression systems for rHA, mentions the use of adenovirus vectors, and specifically describes the integration of HA, capsid protein (M1), and neuraminidase (NA) expressed in insect cells. It also notes that VLP structures produced in insect cells can include baculovirus and Sf9 cell proteins, and concludes with the statement that 'Insect cell derived rHA (RIV4) has been studied extensively by various groups in both pre clinical models and humans.' All key technical facts and context from the quote are present in the document.. The quote directly supports the claim. It explicitly states that recombinant HA (rHA) can be expressed in insect cells, and that RIV4 (Flublok) is an example of an insect cell-derived rHA vaccine. It also references the use of a baculovirus expression vector system (BEVS) for this purpose, as described elsewhere in the document. The quote distinguishes this method from other recombinant expression systems and provides specific details about the use of insect cells and baculovirus, which substantiates the claim that Flublok is produced using a novel platform where recombinant HA is expressed in insect cells using BEVS.",
      "presence_explanation": "The quote appears on page 3 of the document, though with some minor differences in formatting and wording due to OCR correction. The content is semantically equivalent: it discusses both prokaryotic and eukaryotic expression systems for rHA, mentions the use of adenovirus vectors, and specifically describes the integration of HA, capsid protein (M1), and neuraminidase (NA) expressed in insect cells. It also notes that VLP structures produced in insect cells can include baculovirus and Sf9 cell proteins, and concludes with the statement that 'Insect cell derived rHA (RIV4) has been studied extensively by various groups in both pre clinical models and humans.' All key technical facts and context from the quote are present in the document.",
      "support_explanation": "The quote directly supports the claim. It explicitly states that recombinant HA (rHA) can be expressed in insect cells, and that RIV4 (Flublok) is an example of an insect cell-derived rHA vaccine. It also references the use of a baculovirus expression vector system (BEVS) for this purpose, as described elsewhere in the document. The quote distinguishes this method from other recombinant expression systems and provides specific details about the use of insect cells and baculovirus, which substantiates the claim that Flublok is produced using a novel platform where recombinant HA is expressed in insect cells using BEVS.",
      "original_relevance": "This quote discusses the use of insect cells and baculovirus for expressing recombinant HA, specifically referencing RIV4 (Flublok), and distinguishes this method from other recombinant expression systems, directly supporting the claim about the novel production platform."
    },
    {
      "id": "comp_2",
      "quote": "illness and influenza like illness to a quad rival ent in activated BV expression vector HA gene TFF=Tangential Flow Filtration Fig. 1 Generation of rHA using the baculo virus insect cell express from Cox, M. M. & Hashimoto, Y (2011). A fast track influenza virus va Else vier Inc, with permission from Else vier 23.",
      "supports_claim": true,
      "explanation": "The quote appears on page 3 of the document: 'illness and influenza like illness to a quad rival ent in activated BV expression vector HA gene TFF=Tangential Flow Filtration Fig. 1 Generation of rHA using the baculo virus insect cell express from Cox, M. M. & Hashimoto, Y (2011). A fast track influenza virus va Else vier Inc, with permission from Else vier 23.' While the sentence is fragmented and contains OCR artifacts, it clearly references the generation of recombinant HA (rHA) using a baculovirus (BV) insect cell expression system, and mentions tangential flow filtration (TFF) as part of the process. The factual content matches the quote to verify.. The quote directly supports the claim. It references the generation of recombinant HA (rHA) using a baculovirus (BV) insect cell expression system, which is the baculovirus expression vector system (BEVS) described in the claim. The context and technical terms (BV expression vector, HA gene, insect cell express) are consistent with the claim that Flublok is produced using a novel platform where recombinant HA is expressed in insect cells using BEVS. No inference is required; the quote is explicit and directly relevant.",
      "presence_explanation": "The quote appears on page 3 of the document: 'illness and influenza like illness to a quad rival ent in activated BV expression vector HA gene TFF=Tangential Flow Filtration Fig. 1 Generation of rHA using the baculo virus insect cell express from Cox, M. M. & Hashimoto, Y (2011). A fast track influenza virus va Else vier Inc, with permission from Else vier 23.' While the sentence is fragmented and contains OCR artifacts, it clearly references the generation of recombinant HA (rHA) using a baculovirus (BV) insect cell expression system, and mentions tangential flow filtration (TFF) as part of the process. The factual content matches the quote to verify.",
      "support_explanation": "The quote directly supports the claim. It references the generation of recombinant HA (rHA) using a baculovirus (BV) insect cell expression system, which is the baculovirus expression vector system (BEVS) described in the claim. The context and technical terms (BV expression vector, HA gene, insect cell express) are consistent with the claim that Flublok is produced using a novel platform where recombinant HA is expressed in insect cells using BEVS. No inference is required; the quote is explicit and directly relevant.",
      "original_relevance": "This quote references the generation of recombinant HA (rHA) using a baculovirus insect cell expression system, directly supporting the claim that Flublok is produced using this novel platform."
    },
    {
      "id": "comp_3",
      "quote": "Full length cDNA Polyhedrin promoter Transfer plasmid Processing Signals PCR-direct cloning Full length cDNA Linear i zed BV DNA X X Recombination 1. Cell seeding 2 Expa in bio ... Capture Purify DNA removal TFF/Formulation Purification system for the manufacture of RIV4. BV baculo virus. Figure adapted eproduced in insect cells. J Invertebr Pathol 107 Suppl, S31-41 \u00a9 2011",
      "supports_claim": true,
      "explanation": "The quote appears on page 3 of the document, in the following form: 'Full length cDNA Polyhedrin promoter Transfer plasmid Processing Signals PCR-direct cloning Full length cDNA Linear i zed BV DNA X X Recombination 1. Cell seeding 2 Expa in bio ... Capture Purify DNA removal TFF/Formulation Purification system for the manufacture of RIV4. BV baculo virus. Figure adapted eproduced in insect cells. J Invertebr Pathol 107 Suppl, S31-41 \u00a9 2011'. The factual content and technical details match the quote to verify, including the mention of baculovirus (BV), insect cells, and the manufacturing steps for RIV4 (Flublok).. The quote explicitly describes the use of baculovirus (BV) and insect cells in the manufacture of RIV4 (Flublok), referencing the process steps and the use of a polyhedrin promoter, which is characteristic of the baculovirus expression vector system (BEVS). This directly supports the claim that Flublok is produced using a novel platform in which recombinant HA is expressed in insect cells using BEVS.",
      "presence_explanation": "The quote appears on page 3 of the document, in the following form: 'Full length cDNA Polyhedrin promoter Transfer plasmid Processing Signals PCR-direct cloning Full length cDNA Linear i zed BV DNA X X Recombination 1. Cell seeding 2 Expa in bio ... Capture Purify DNA removal TFF/Formulation Purification system for the manufacture of RIV4. BV baculo virus. Figure adapted eproduced in insect cells. J Invertebr Pathol 107 Suppl, S31-41 \u00a9 2011'. The factual content and technical details match the quote to verify, including the mention of baculovirus (BV), insect cells, and the manufacturing steps for RIV4 (Flublok).",
      "support_explanation": "The quote explicitly describes the use of baculovirus (BV) and insect cells in the manufacture of RIV4 (Flublok), referencing the process steps and the use of a polyhedrin promoter, which is characteristic of the baculovirus expression vector system (BEVS). This directly supports the claim that Flublok is produced using a novel platform in which recombinant HA is expressed in insect cells using BEVS.",
      "original_relevance": "This quote outlines the steps in the manufacture of RIV4, including the use of baculovirus (BV) and insect cells, which directly supports the claim about the production platform for Flublok."
    }
  ],
  "rejected_evidence": [
    {
      "id": 4,
      "quote": "Insect cell derived rHA (RIV4) has been studied extensively by various groups in both pre clinical models and humans. The rHA contained in RIV4 differs from that expressed in other systems in terms of specific structural features, the nature of the source material and the manufacturing process, which have an impact on certain aspects of vaccine safety and efficacy (Fig. 2).",
      "reason": "does not support claim",
      "original_explanation": "This quote affirms that RIV4 (Flublok) uses recombinant HA derived from insect cells, highlighting the unique manufacturing process relevant to the claim."
    }
  ],
  "model_used": "gpt-4.1"
}